188jili te
2025-01-10   

188jili te NoneAndrew P. Strada’s Dec. 1 column (” A Trump voter’s modest proposal for moving ahead without rancor or finger-pointing ”) reasonably calls for calm in spite of political differences. Strada sounds like one with whom I could have a cordial discussion in spite of my being a centrist Democrat. However, he lost me in his failure to mention extreme GOP rhetoric while lamenting ”hyperbolic ad hominem attacks comparing Trump to Adolf Hitler and Trump voters to fascists....” Why no mention of the same types of attacks by Donald Trump or his supporters? Strada is right to criticize Barack Obama’s guns and religion comment and Hillary Clinton’s basket of deplorables gaffe. I also think the Democratic Party has lost touch with its original constituency, the middle and blue-collar classes. However, Trump’s Thanksgiving message referred to “Radical Left Lunatics.” His accusation that Democrats are trying “to destroy” America was hyperbolic as was his violent talk about Liz Cheney . Her actual offense? Standing up for what she felt was right, political consequences notwithstanding. Add his witty but insulting names like George Slopadopolous instead of Stephanopolous or Gavin Newscum instead of Newsome. RECOMMENDED • cleveland .com A Trump voter’s modest proposal for moving ahead without rancor or finger-pointing: Andrew P. Strada Dec. 1, 2024, 5:22 a.m. Ohio’s $1B private school voucher program - where’s the accountability? Nov. 29, 2024, 2:53 p.m. Face it. Both sides often refuse to admit their respective faults. Bob Sheridan, Lyndhurst

BILLERICA, Mass.--(BUSINESS WIRE)--Nov 22, 2024-- Quanterix Corporation (NASDAQ: QTRX) today announced that it received a notice (the “Notice”) on November 21, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Form 10-Q"), it is no longer in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. Under Nasdaq rules, the Company has 60 calendar days from receipt of the Notice, or until January 20, 2025, to submit a plan to regain compliance with the Rule. On November 12, 2024, the Company previously announced that it would be delayed in filing the Form 10-Q due to the need to restate the Company’s audited consolidated financial statements as of December 31, 2023 and 2022 and for each of the three years in the period ended December 31, 2023, and its unaudited consolidated financial statements for the quarterly and year-to-date (as applicable) periods ended March 31, 2022, June 30, 2022, September 30, 2022, March 31, 2023, June 30, 2023, September 30, 2023, March 31, 2024 and June 30, 2024. The Notice from Nasdaq is standard practice in the event of a delayed periodic financial report filing and was anticipated. The Company is continuing to work expeditiously to complete the filing of the Form 10-Q and remains on track to complete the restatement and all required filings by the end of 2024. This announcement is made in compliance with Nasdaq Listing Rule 5250(b)(2). About Quanterix From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company’s Simoa ® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 3,100 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https://www.quanterix.com or follow us on Twitter and LinkedIn . Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this press release are based on Quanterix’s expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’s actual results to differ from those expressed or implied in the forward-looking statements in this press release include, but are not limited to, that the Company may have underestimated the scope and impact of the restatement of certain of its financial statement and the risk that the Company’s restated financial statements may take longer to complete than expected, as well as those described in our periodic reports filed with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available. View source version on businesswire.com : https://www.businesswire.com/news/home/20241122959546/en/ CONTACT: Media: media@quanterix.comInvestor Relations: Amy Achorn (978) 488-1854 ir@quanterix.com KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH TECHNOLOGY HEALTH MEDICAL DEVICES SOURCE: Quanterix Corporation Copyright Business Wire 2024. PUB: 11/22/2024 05:00 PM/DISC: 11/22/2024 05:02 PM http://www.businesswire.com/news/home/20241122959546/enBILLERICA, Mass.--(BUSINESS WIRE)--Nov 22, 2024-- Quanterix Corporation (NASDAQ: QTRX) today announced that it received a notice (the “Notice”) on November 21, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Form 10-Q"), it is no longer in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. Under Nasdaq rules, the Company has 60 calendar days from receipt of the Notice, or until January 20, 2025, to submit a plan to regain compliance with the Rule. On November 12, 2024, the Company previously announced that it would be delayed in filing the Form 10-Q due to the need to restate the Company’s audited consolidated financial statements as of December 31, 2023 and 2022 and for each of the three years in the period ended December 31, 2023, and its unaudited consolidated financial statements for the quarterly and year-to-date (as applicable) periods ended March 31, 2022, June 30, 2022, September 30, 2022, March 31, 2023, June 30, 2023, September 30, 2023, March 31, 2024 and June 30, 2024. The Notice from Nasdaq is standard practice in the event of a delayed periodic financial report filing and was anticipated. The Company is continuing to work expeditiously to complete the filing of the Form 10-Q and remains on track to complete the restatement and all required filings by the end of 2024. This announcement is made in compliance with Nasdaq Listing Rule 5250(b)(2). About Quanterix From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company’s Simoa ® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 3,100 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https://www.quanterix.com or follow us on Twitter and LinkedIn . Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this press release are based on Quanterix’s expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’s actual results to differ from those expressed or implied in the forward-looking statements in this press release include, but are not limited to, that the Company may have underestimated the scope and impact of the restatement of certain of its financial statement and the risk that the Company’s restated financial statements may take longer to complete than expected, as well as those described in our periodic reports filed with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available. View source version on businesswire.com : https://www.businesswire.com/news/home/20241122959546/en/ CONTACT: Media: media@quanterix.comInvestor Relations: Amy Achorn (978) 488-1854 ir@quanterix.com KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH TECHNOLOGY HEALTH MEDICAL DEVICES SOURCE: Quanterix Corporation Copyright Business Wire 2024. PUB: 11/22/2024 05:00 PM/DISC: 11/22/2024 05:02 PM http://www.businesswire.com/news/home/20241122959546/en

Fever tickets 2025: Cheapest prices, seat map, full schedule for WNBA games in Indianapolis | Sporting NewsAs science continues its evolution, discoveries and technologies can act like a master key that open doors leading to novel advancements. Artificial intelligence is one such key, making innovations possible by solving complex problems, automating tasks and enabling research that would have been impossible, or very time-consuming, without it. Mohammad Hosseini But do we want to do research on all topics, and shall we try the AI master key on every door? To explore this question, let’s consider the use of AI by genomics experts as an example. In recent years, genomics experts have added unbelievable depth to what we know about the world and ourselves. For example, genetics researchers have revealed facts about when certain animals and plants were domesticated. In another example, researchers used DNA from 30,000-year-old permafrost to create fertile samples of a plant called narrow-leafed campion. Importantly, genetic engineering has facilitated extraordinary advances in the treatment of complicated conditions, such as sickle-cell anemia. Thanks to AI, we are witnessing a dramatic increase in the pace and scalability of genomic exploration. But given the risks and possible consequences of AI use in science, should we rush headlong into using AI in all kinds of projects? One relevant example is research on Neanderthals, our closest relatives, who lived about 40,000 years ago. Neanderthals have been studied for several years now through genetic investigation of their fossils and their DNA. Genetic engineering can potentially use ancient DNA and genome editing methods to re-create a Neanderthal or aspects of a Neanderthal’s genetics and physiology. To do this, scientists could start by figuring out the DNA sequence of a Neanderthal by comparing it with the DNA of modern humans, because they are closely related. Then, scientists could use the gene-editing tool known as CRISPR to swap out parts of human DNA with Neanderthal DNA. This process would require a lot of trial and error and might not succeed soon. But based on what we know about genetics, if something is possible, AI can help make it happen faster, cheaper and with less effort. Scientists are excited about these developments because they could facilitate new discoveries and open up many research opportunities in genetic research. With or without AI, research on Neanderthals will proceed. But the extraordinary power of AI could give the final push to these discoveries and facilitate this kind of resurrection. At that point, the scientific community must develop norms and guidelines about how to treat these resurrected beings with dispositions very similar to humans. We would need to carefully consider their rights and well-being almost in the same way as when humans are involved and not as research subjects or artifacts of scientific curiosity. These ethical issues are discussed in more detail in a new paper published in the journal Nature Machine Intelligence. A more holistic question to consider is: Should we prioritize the use of resource-intensive AI, researchers’ time and public funds to resurrect extinct beings? Or should we invest these resources into conserving species that are critically endangered today to prevent biodiversity from more degradation? Hosseini is an assistant professor in the Department of Preventive Medicine at Northwestern University’s Feinberg School of Medicine. He wrote this for The Chicago Tribune . Get opinion pieces, letters and editorials sent directly to your inbox weekly!

Ranking All Of Wicked's Songs Based On Emotional Impact

Las Vegas (3-12) at New Orleans (5-10) Sunday, 1 p.m. EST, Fox BetMGM NFL odds: Raiders by 1 Against the spread: Raiders 6-9; Saints 6-9 Series record: Tied 7-7-1 Last meeting: Saints beat Raiders 24-0 on Oct. 30, 2023, at New Orleans. Last week: Raiders beat Jaguars 19-14 ; Saints lost to Packers 34-0 . Raiders offense: overall (28), rush (32), pass (14), scoring (29) Raiders defense: overall (12), rush (13), pass (9), scoring (27) Saints offense: overall (19), rush (13), pass (23), scoring (22) Saints defense: overall (30), rush (30), pass (28), scoring (T17) Turnover differential: Raiders minus-17; Saints minus-1 After his 11 catches for 99 yards last week, rookie tight end Brock Bowers has a team-leading 101 catches for a team-high 1,067 yards and four TDs. As one of few healthy skill players left on New Orleans' offense, tight end Juwan Johnson has become more prominent in the game plan. The former Penn State and Oregon receiver, who was converted to a tight end during his third NFL season (2022), now ranks second on the club in catches this season with 38 and yards receiving with 402, while his three TD catches are tied for third on the team. Bowers will test New Orleans' coverage scheme. Those Saints responsible for containing Bowers could include linebackers Demario Davis and Peter Werner, as well as safeties Will Harris and Tyrann Mathieu. Raiders guard Jordan Meredith (ankle), linebacker Kana'I Mauga (calf) and guard Jackson Powers-Jordan (quadriceps/ankle) were all listed on Las Vegas' injury report this week. The Saints listed nine players on their injury report this week, including QB Derek Carr (left hand), running back Alvin Kamara (groin), center Erik McCoy (elbow) and guard Lucas Patrick (knee), who all missed practice time. Those limited at practice this week included defensive tackle Nathan Shepherd (eye), defensive end Payton Turner (ankle), receiver Marquez Valdes-Scantling (chest) and Johnson ( foot). The Raiders have won two of the past three, while the Saints have won four of the past six. The teams have met eight times previously in New Orleans, with the Saints winning four and the Raiders winning three. The clubs' first ever meeting was a 21-all tie in New Orleans in 1971 at the old Tulane Stadium. Raiders QB Aidan O'Connell completed 24 of 38 passes (63.2 percent) for 257 yards without an interception last week. He has not thrown an interception in three of his past four games. ... Bowers last week became the second rookie in NFL history (joining Odell Beckham Jr.) and the third TE ever (joining Zach Ertz and Evan Engram) with 10 or more catches in four games in a season. Bowers’ 1,067 yards receiving leads all NFL tight ends this season and he needs just 10 more yards to surpass Hall of Famer Mike Ditka (1,076 in 1961) for the most by rookie TE. ... Veteran RB Ameer Abdullah had season-high 85 scrimmage yards (47 receiving, 38 rushing) and a TD rushing last week, giving him a TD in two straight games. He needs 75 scrimmage yards for his third season with 500 (along with 2015 and 2017). ... RB Alexander Mattison had 56 scrimmage yards and a TD rushing in Week 16. He caught a TD pass in his only career game in New Orleans, when he was with Minnesota in 2022. ... DT Adam Butler has a tackle for loss in five of his past six games and at least half a sack in three of his past four. ... DE K’lavon Chaisson had a sack last week, giving him a tackle for loss in four straight games. ... S Isaiah Pola-Mao had nine tackles and the first two forced fumbles of his career last week. ... Saints rookie QB Spencer Rattler passed for 153 yards and rushed for 28 yards in Week 16, but also was intercepted and lost a fumble. He is 0-4 as an NFL starter. ... Versatile veteran RB Alvin Kamara, who hopes to return from a groin injury before this season ends, needs 7 scrimmage yards for his fourth 1,500-yard season and needs 50 yards rushing for his first 1,000-yard rushing season. ... WR Marquez Valdes-Scantling has a TD catch in three of his past four home games. TE Foster Moreau had 91 catches, 1,107 yards receiving and 12 TD catches in 61 games with the Raiders from 2019 to 2022. Moreau has 25 catches for 335 yards and four TDs this season. ... DE Cameron Jordan has a tackle for loss in each of his past two games. ... DE Carl Granderson has sack in two of his past three home games. ... DT Khalen Saunders had career-high two passes defensed and a tackle for loss last week. ... DT Bryan Bresee, a 2023 first-round draft choice out of Clemson, has a career-best 7 1/2 sacks in 2024. ... DE Chase Young has at least half a sack and a tackle for loss in three of his past four home games. ... LB Demario Davis has 114 tackles in 2024 and is one of three players (along with Eric Kendricks and Bobby Wagner) with 100 or more tackles in each of the past eight seasons. ... S Tyrann Mathieu has 99 passes defensed. He's intercepted a pass in each of his past two games against the Raiders. Bowers is a good bet to have another big game against a defense that ranks 28th in the NFL against the pass. AP NFL: https://apnews.com/hub/NFLhttps://arab.news/2z8sv NFL Commissioner Roger Goodell on Wednesday said the league is aware of a lawsuit that accuses musician Jay-Z of rape but said it is not impacting the NFL’s partnership with the rap mogul’s Roc Nation label, which produces the Super Bowl halftime show. An amended civil lawsuit filed in federal court on Sunday alleges Jay-Z and Sean “Diddy” Combs raped a 13-year-old girl during a party in New York in 2000. Jay-Z and Combs have denied the allegations. “We’re aware of the civil allegations and Jay-Z’s really strong response to that,” Goodell said after the conclusion of the league’s winter meetings in Texas. “We know the litigation is happening now. From our standpoint, our relationship is not changing with them, including our preparations for the next Super Bowl.” Roc Nation has helped produce the past five Super Bowl halftime shows and Jay-Z’s wife, Beyonce, is scheduled to perform at halftime of the upcoming Ravens vs. Texans game on Christmas Day in Houston, according to Sports Illustrated. The lawsuit was originally filed in October in the Southern District of New York and at that time did not name Jay-Z as a defendant, though the amended lawsuit says that Jay-Z was identified as “Celebrity A” on the original complaint. Jay-Z, whose real name is Shawn Carter, has blasted the lawsuit, calling it part of a “blackmail attempt” by the plaintiff’s lawyer. Tony Buzbee, the Texas lawyer representing the girl who filed Sunday’s lawsuit, has filed at least 20 civil lawsuits against Combs accusing him of sexual misconduct. Buzbee said Jay Z’s relationship with the NFL had nothing to do with him. “My job is to represent my clients zealously and ethically. And that’s what I intend to do,” he said in response to a request for comment. Combs has denied all allegations against him. He is currently in jail on federal sex trafficking charges, to which he has pleaded not guilty. The lawsuit alleges that the unnamed girl was drugged and raped by both Jay-Z and Combs at a party hosted by Combs following the MTV Music Awards in 2000, which was held in New York.

Thousands of UK social media users experiencing ongoing Meta blackoutLawmakers react to Hunter Biden pardonIfedi starts at left tackle for Browns in prime-time matchup against AFC North-leading Steelers

The UN General Assembly on Wednesday overwhelmingly adopted a resolution calling for an immediate and unconditional ceasefire in Gaza, a symbolic gesture rejected by the United States and Israel. The resolution -- adopted by a vote of 158-9, with 13 abstentions -- urges "an immediate, unconditional and permanent ceasefire," and "the immediate and unconditional release of all hostages" -- wording similar to a text vetoed by Washington in the Security Council last month. At that time, Washington used its veto power on the Council -- as it has before -- to protect its ally Israel, which has been at war with Hamas in the Gaza Strip since the Palestinian militant group's October 7, 2023 attack. It has insisted on the idea of making a ceasefire conditional on the release of all hostages in Gaza, saying otherwise that Hamas has no incentive to free those in captivity. Deputy US Ambassador Robert Wood repeated that position Wednesday, saying it would be "shameful and wrong" to adopt the text. Ahead of the vote, Israel's UN envoy Danny Danon said: "The resolutions before the assembly today are beyond logic. (...) The vote today is not a vote for compassion. It is a vote for complicity." The General Assembly often finds itself taking up measures that cannot get through the Security Council, which has been largely paralyzed on hot-button issues such as Gaza and Ukraine due to internal politics, and this time is no different. The resolution, which is non-binding, demands "immediate access" to widespread humanitarian aid for the citizens of Gaza, especially in the besieged north of the territory. Dozens of representatives of UN member states addressed the Assembly before the vote to offer their support to the Palestinians. "Gaza doesn't exist anymore. It is destroyed," said Slovenia's UN envoy Samuel Zbogar. "History is the harshest critic of inaction." That criticism was echoed by Algeria's deputy UN ambassador Nacim Gaouaoui, who said: "The price of silence and failure in the face of the Palestinian tragedy is a very heavy price, and it will be heavier tomorrow." Hamas's October 2023 attack on southern Israel resulted in the deaths of 1,208 people, mostly civilians, according to an AFP tally based on official figures. That count includes hostages who died or were killed while being held in Gaza. Militants abducted 251 hostages, 96 of whom remain in Gaza, including 34 the Israeli military says are dead. Israel's retaliatory offensive in Gaza has killed at least 44,805 people, a majority of them civilians, according to data from the Hamas-run health ministry that is considered reliable by the United Nations. "Gaza today is the bleeding heart of Palestine," Palestinian UN Ambassador Riyad Mansour said last week during the first day of debate in the Assembly's special session on the issue. "The images of our children burning in tents, with no food in their bellies and no hopes and no horizon for the future, and after having endured pain and loss for more than a year, should haunt the conscience of the world and prompt action to end this nightmare," he said, calling for an end to the "impunity." After Wednesday's vote, he said "we will keep knocking on the doors of the Security Council and the General Assembly until we see an immediate and unconditional ceasefire put in place." The Gaza resolution calls on UN Secretary-General Antonio Guterres to present "proposals on how the United Nations could help to advance accountability" by using existing mechanisms or creating new ones based on past experience. The Assembly, for example, created an international mechanism to gather evidence of crimes committed in Syria starting from the outbreak of civil war in 2011. A second resolution calling on Israel to respect the mandate of the UN agency supporting Palestinian refugees (UNRWA) and allow it to continue its operations was passed Wednesday by a vote of 159-9 with 11 abstentions. Israel has voted to ban the organization starting January 28, after accusing some UNRWA employees of taking part in Hamas's devastating attack. abd/sst/jgc/nro/des

Botafogo won the Copa Libertadores for the first time in their history with a 3-1 victory over fellow Brazilians Atletico Mineiro on Saturday. Botafogo played almost the entire match with ten men after Gregore was sent off in the first minute but they showed impressive spirit and resilience to secure victory at River Plate's Monumental Stadium in Buenos Aires. It is the sixth straight season that a Brazilian club has won the Libertadores, the top competition for South American clubs. The 120-year-old Botafogo, the Rio club who have twice won the Brazilian championship, have a rich history, including producing greats such as World Cup winners Garrincha, Didi, Nilton Santos and Mario Zagallo. But they have long suffered taunts from their rivals about their failure to win the continental title -- a jibe that can be made no more. Midfielder Gregore was shown a red card after a wild, high challenge on Fauto Vera, forcing Botafogo to adjust their game plan, but Atletico failed to press home their numerical advantage. Veteran forward Hulk had an effort from outside the box saved by John but the team from Belo Horizonte created little pressure. Sensing the game might not be the rearguard action they might have expected, Botafogo began to show more attacking intent and they were rewarded in the 35th minute. Marlon Freitas's shot from the edge of the box ricocheted around a crowded box before the ball fell to Luiz Henrique, who fired home from close range. To their credit, Botafogo didn't retreat to defend their slim advantage and they were able to double their lead in the 44th minute. Atletico defender Guilherme Arana attempted to shepherd the ball back to goalkeeper Everson, but Luiz Henrique snuck between the pair and went down under challenge from the keeper. After a VAR review, a penalty was awarded and Alex Telles confidently smashed home the spot kick to give Botafogo an unlikely 2-0 lead at the break. Atletico, who won the Libertadores in 2013, made a triple substitution at the interval and it paid off swiftly with Eduardo Vargas heading in from a corner. Inevitably, there was late pressure from Atletico, but Botafogo made sure of the victory when Junior Santos finished off a counter-attack deep in stoppage time. With the win, Botafogo earns the final of 32 places in next year's FIFA Club World Cup to be held in the United States. The club, owned by American businessman John Textor, also has a chance to complete a double by winning what would be their third Brazilian league title -- they currently lead Serie A by three points with two games remaining. Luis Henrique, whose fine form this season has seen him break into the Brazil squad, said the win was an emotional one for him and the team. "Many people tried to stop me, but I know that God is with me, my family is with me, and I have to keep my feet on the ground because there is still more to come," the 23-year-old striker said. "I want to thank Botafogo a lot, Botafogo needs to be at the top, because it's a club that has been working hard, that has been doing a lot on a daily basis." sev/js

As science continues its evolution, discoveries and technologies can act like a master key that open doors leading to novel advancements. Artificial intelligence is one such key, making innovations possible by solving complex problems, automating tasks and enabling research that would have been impossible, or very time-consuming, without it. Mohammad Hosseini But do we want to do research on all topics, and shall we try the AI master key on every door? To explore this question, let’s consider the use of AI by genomics experts as an example. In recent years, genomics experts have added unbelievable depth to what we know about the world and ourselves. For example, genetics researchers have revealed facts about when certain animals and plants were domesticated. In another example, researchers used DNA from 30,000-year-old permafrost to create fertile samples of a plant called narrow-leafed campion. Importantly, genetic engineering has facilitated extraordinary advances in the treatment of complicated conditions, such as sickle-cell anemia. Thanks to AI, we are witnessing a dramatic increase in the pace and scalability of genomic exploration. Listen now and subscribe: Apple Podcasts | Spotify | Stitcher | RSS Feed | SoundStack | All Of Our Podcasts But given the risks and possible consequences of AI use in science, should we rush headlong into using AI in all kinds of projects? One relevant example is research on Neanderthals, our closest relatives, who lived about 40,000 years ago. Neanderthals have been studied for several years now through genetic investigation of their fossils and their DNA. Genetic engineering can potentially use ancient DNA and genome editing methods to re-create a Neanderthal or aspects of a Neanderthal’s genetics and physiology. To do this, scientists could start by figuring out the DNA sequence of a Neanderthal by comparing it with the DNA of modern humans, because they are closely related. Then, scientists could use the gene-editing tool known as CRISPR to swap out parts of human DNA with Neanderthal DNA. This process would require a lot of trial and error and might not succeed soon. But based on what we know about genetics, if something is possible, AI can help make it happen faster, cheaper and with less effort. Scientists are excited about these developments because they could facilitate new discoveries and open up many research opportunities in genetic research. With or without AI, research on Neanderthals will proceed. But the extraordinary power of AI could give the final push to these discoveries and facilitate this kind of resurrection. At that point, the scientific community must develop norms and guidelines about how to treat these resurrected beings with dispositions very similar to humans. We would need to carefully consider their rights and well-being almost in the same way as when humans are involved and not as research subjects or artifacts of scientific curiosity. These ethical issues are discussed in more detail in a new paper published in the journal Nature Machine Intelligence. A more holistic question to consider is: Should we prioritize the use of resource-intensive AI, researchers’ time and public funds to resurrect extinct beings? Or should we invest these resources into conserving species that are critically endangered today to prevent biodiversity from more degradation?

Raiders and Saints meet with prominent players nearing statistical milestones

Related hot word search:

Previous: 188jili site
Next: how to deposit in 188 jili